Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Heart valve company Edwards Lifesciences has completed its acquisition of certain assets of the CardioVations division of Ethicon.
Subscribe to our email newsletter
CardioVations’ product line includes the Port-Access products for performing minimally invasive cardiac valve procedures. The CardioVations product line is expected to generate sales of more than $20 million in 2008.
Anita Bessler, corporate vice president for heart valve and cardiac surgery systems, said: “We are pleased to add CardioVations’ unique products to Edwards’ portfolio of innovative aortic and mitral valve replacement technologies. This complementary product line will give our surgical partners new avenues to optimize patient outcomes.”